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Abstract
Purpose The aim of this study was to describe clinical signs
and complications of Fuchs uveitis syndrome (FUS) with on-
set in childhood.
Methods Ophthalmologic findings and complications in pa-
tients with FUS becoming manifest before the age of 16 years
were analyzed in a retrospective study at a tertiary referral
uveitis center. Inclusion criteria were the presence of patho-
gnomonic FUS findings at any time point and exclusion of
any systemic immune-mediated or infectious disease.
Results A total of 23 patients (male=16, female=7) with ju-
venile FUS (unilateral n=20, bilateral n=3 patients) were in-
cluded in the study. Mean ages at uveitis and FUS diagnosis
were 12.0±4.2 and 22.7±10.7 years, respectively. In six pa-
tients, inflammation was noted at age≤7 years. The following
inflammatory signs were observed in a total of 26 eyes: ≤ 1+
anterior chamber cell grade (n=26), vitreous cells (n=24), fine
keratic precipitates (KPs; n=23), stellate KPs (n=11), mutton-
fat KPs (n=23), diffuse (n=24) or inferior (n=8) distribution
of KPs, Koeppe nodules (n=10), and iris heterochromia (n=
14). A representative subgroup of patients (n=5) is shown
who presented with non-specific clinical signs in the begin-
ning and in whom typical FUS signs became manifest only at
a later stage. Secondary complications such as cataract (n=
19), ocular hypertension (n=3), or glaucomatous disc damage
(n=2) were found after a mean uveitis duration of 11.6, 19.5,
and 20.3 years, respectively.
Conclusion FUS may begin in early childhood, and the char-
acteristic findings may not be present at onset of disease. The
diagnosis is often delayed for years, occasionally with the
consequence of overtreatment with anti-inflammatory drugs.
Keywords Fuchs uveitis syndrome . Children . Diagnosis .
Clinical signs . Complications
Introduction
Fuchs uveitis syndrome (FUS) describes a chronic, granulo-
matous, low-grade, and often unilateral anterior segment in-
flammation of the eye. This syndrome was first described by
Ernst Fuchs in 1902 [1]. Typical clinical features include
mutton-fat or stellate keratic precipitates (KPs) on the entire
corneal endothelium surface, a low anterior chamber cell
grade, some cells and/or opacities in the anterior vitreous,
the absence of posterior synechiae, and, commonly, iris atro-
phy [2]. Iris nodules may be observed on the pupillary margin
(Koeppe) and also in the iris stroma (Busacca) [3, 4]. FUS
patients comprise about 6.2 % [5] to 6.9 % [6] of the uveitis
cases at tertiary referral centers and up to 12 % when consid-
ering only patients with chronic anterior uveitis [7]. In certain
countries, for example, in Italy, these patients may account for
up to 22.7 % of uveitis cases in general or up to 45 % of cases
when considering only patients with anterior uveitis [8]. Only
a small amount of clinical data about FUS in children have
been published up to now [9, 10].
A delay from the manifestation of the first symptoms, de-
tecting the presence of uveitis, and correctly diagnosing FUS
represents a common problem [11]. Patients with FUS are
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frequently asymptomatic for years before diagnosis. Iris
heterochromia may be absent or subtle, especially in patients
with a brown iris [12–14]. An infectious etiology has been
discussed recently, e.g., possible associations with toxoplas-
mosis [15, 16], rubella virus [17–21], or herpes viruses [20,
22]. However, FUS is still diagnosed by recognizing the pat-
terns of typical clinical signs and is not primarily based on any
laboratory testing.
The aim of this study was to characterize the manifestation
of FUS in children, including early clinical signs, and occur-
rence of complications during further follow-up.
Methods
Medical records of all children with FUS (onset of disease
before 16 years of age) seen between 1997 and 2011 at the
Department of Ophthalmology at the St. Franziskus Hospital
Muenster (Germany) were retrospectively reviewed. No institu-
tional review board approval is required for such chart review
studies in Germany. Uveitis in childhoodwas defined as an onset
of disease before 16 years of age, according to childhood
definition in pediatric nomenclature and to allow comparability
to uveitis associated with juvenile idiopathic arthritis.
FUS diagnosis was based on the following criteria [2, 3, 11,
12, 14, 23]: chronic anterior uveitis with≤1+ cell grade in the
anterior chamber and insidious onset of flare; absence of sig-
nificant acute exacerbations [24]; fine and stellate KPs dif-
fusely spread on the entire corneal endothelium; diffuse iris
atrophy with or without obvious heterochromia; and lack of
posterior synechiae. Rheumatologic examinations included a
review of systems, laboratory tests (including HLA-B27,
complete blood count, urine analysis, angiotensin-converting
enzyme, and anti-nuclear antibodies [ANA]), and chest X-ray
examination if an underlying systemic disease was suspected.
Any associated immune-mediated systemic (e.g., sarcoidosis,
juvenile idiopathic arthritis) or infectious diseases (e.g., lues,
borreliosis, or tuberculosis) were excluded by laboratory test-
ing and medical history.
Medical history and ophthalmologic findings such as best-
corrected visual acuity (BCVA), slit-lamp examination,
applanation tonometry (Goldmann), gonioscopy, and fundos-
copy were recorded according to a standardized protocol,
which was previously introduced for documenting patients
with JIA-associated uveitis [25]. Features of KPs regarding
form (mutton-fat, fine, or stellate [2]), pigmentation (with-
out/with), and distribution (disseminated on entire corneal en-
dothelium or inferior half of corneal endothelium) were doc-
umented. Data including current age, gender, age at first diag-
nosis of uveitis, duration of uveitis prior to first presentation to
our tertiary uveitis referral center, age at diagnosis of FUS,
ocular complications (cataract, ocular hypertension, and
glaucomatous disc damage), surgical eye procedures, and du-
ration of follow-up were also collected. Sustained intraocular
pressure (IOP)≥21 mmHg without pathological disc cupping
was defined as ocular hypertension, whereas the presence of
Table 1 Epidemiological data. Patients (23 patients; 26 eyes) with
Fuchs uveitis syndrome becoming manifest before the age of 16 years
Sex
Male (N/%) 16/69.6 %
Female (N/%) 7/30.4 %
Eyes with uveitis
Unilateral (N/%) 20/87 %
Bilateral (N/%) 3/13 %
Age (years) at uveitis diagnosis 12.0 ±4.2 (4.0 – 16.0)
Age (years) at FUS diagnosis 22.7 ±10.7 (9.0 – 37.5)
Age (years) at first visit to reporting
uveitis center
23.8 ±10.9 (8.8 – 37.5)
Mean follow-up (years) since uveitis
diagnosis
14.0 ±11.3 (0.03 – 36.5)
Table 2 Type of keratic
precitipates (KPs) by time point
of first documentation. Patients
(23 patients; 26 eyes) with Fuchs
uveitis syndrome becoming
manifest before the age of 16
years
N (eyes)/% Age (years) at initial
documentation
mean±SD (range)
Years after uveitis
diagnosis
mean±SD (range)
Type of KPs
Fine 23/88.5 % 21.9±11.3 (6.9 – 37.5) 9.0±10.5 (0 – 36.5)
Stellate 11/42.3 % 18.7±8.9 (7.4 – 37.7) 7.5±8.9 (0 – 27.4)
mutton-fat 23/88.5 % 22.6±10.5 (9.0 – 37.5) 10.6±11.0 (0 – 36.5)
Localization of KPs
Inferior 8/30.8 % 12.4±4.5 (6.8 – 19.9) 1.8±2.9 (0 – 9.0)
Diffuse 24/92.3 % 22.8±10.6 (9.0 – 37.5) 10.6±10.8 (0 – 36.5)
Pigmentation of KPs
No 23/88.5 % 23.5±12.1 (6.8 – 37.5) 10.9±12.0 (0 – 36.5)
Yes 8/30.8 % 27.3±12.3 (14.9 – 37.5) 13.7±11.6 (0.8 – 36.5)
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glaucomatous disc damage was defined as glaucoma [26].
Data were analyzed concerning the first time typical inflam-
matory signs and complications of FUS were documented.
Descriptive statistical analysis was performed using
GraphPad Prism version 6.0e (GraphPad Software Inc., La
Jolla, CA, USA). Values are provided as mean±standard de-
viation (SD) and range (minimum – maximum).
Results
In a retrospective chart analysis, 23 patients (female n=7, male
n=16) with FUS and onset before 16 years of age were iden-
tified (in six patients FUS was noted at≤7 years of age). This
represented 7.8% of all FUS patients and 3.2% of patients with
uveitis onset before 16 years of age whowere in the database of
the tertiary uveitis center during this time period. The epidemi-
ological data are summarized in Table 1. In three of the patients,
both eyes were affected. The mean age at uveitis diagnosis was
12.0±4.2 years. Patients were referred to us following a mean
duration of uveitis of 11.9±11.3 years. Topical steroids were
applied in 14 out of 23 patients prior to FUS diagnosis.
Different types of KPs were documented (Table 2), and also
a change in KP type during the course of disease was obvious
for certain patients. At initial documentation, fine KPs were
found in 20 eyes (76.9 %), whereas stellate KPs were present
in nine eyes (34.6 %) and mutton-fat KPs in 19 eyes (73.1 %).
During follow-up, new fine KPs were found in three eyes, new
stellate KPs in two eyes, and new mutton-fat KPs in four eyes.
Diffuse KPs on the entire corneal endothelium were observed
in 19 eyes at initial documentation and in a total of 24 eyes
(92.3 %) after a mean uveitis duration of 10.6 years (range 0 –
36.5). Inferior KPs were documented in eight eyes (30.5 %)
after a mean uveitis duration of 1.8 years (range 0 – 9.0; five
eyes with inferior KPs documented in the first year after uveitis
diagnosis, three eyes with inferior KPs documented within
2.5 years). In eight eyes (30.8 %) pigmented KPs were ob-
served after a mean of 13.7 years (range 0.8 - 36.5) following
uveitis onset. Analyzing the subgroup of patients who had been
seen at our tertiary uveitis center already before 16 years of age
and not later on (six patients; eight eyes; Table 3), fine KPswere
documented 0.6±0.4 years after uveitis diagnosis, whereas stel-
late or mutton-fat KPs were documented slightly later (0.7±0.6
and 1.3±1.3 years after uveitis diagnosis, respectively). Fur-
thermore, inferior KPs were documented earlier than a diffuse
Table 3 Type of keratic
precitipates (KPs) by time point
of first documentation. Patients
(six patients; eight eyes) with
Fuchs uveitis syndrome seen at
the tertiary uveitis center before
the age of 16 years
N (eyes)/% Age (years) at initial
documentation
mean±SD (range)
Years after uveitis
diagnosis
mean±SD (range)
Type of KPs
fine 8/100 % 11.6±3.4 (6.9 – 15.4) 0.6±0.4 (0 – 1.3)
stellate 5/62.5 % 11.1±3.0 (7.4 – 14. 9) 0.7±0.6 (0 – 1.8)
mutton-fat 8/100 % 12.3±2.4 (9.0 – 15.2) 1.3±1.3 (0 – 3.06)
Localization of KPs
inferior 5/62.5 % 10.1±3.6 (6.8 – 15.2) 0.8±0.6 (0 – 1.8)
diffuse 7/87.5 % 12.3±2.2 (9.0 – 15.2) 1.2±1.2 (0 – 3.1)
Pigmentation of KPs
No 7/87.5 % 11.5±3.3 (6.8 – 15.2) 0.9±1.1 (0 – 2.9)
Yes 2/25 % 15.0±0.2 (14.9 – 15.2) 0.9±0.1 (0.8 – 1)
Table 4 Clinical signs with age
at initial documentation and
observation interval after uveitis
diagnosis. Patients (23 patients;
26 eyes) with Fuchs uveitis
syndrome becoming manifest
before the age of 16 years.
n.a not applicable
N (eyes)/% Age (years) at initial
documentation
mean±SD (range)
Years after uveitis
diagnosis
mean±SD (range)
AC cell-grade≤1+ 26/100 % 12.0 ±4.2 (4.0 – 16.0) n.a
Koeppe nodules 10/38.5 % 21.7±8.8 (10.5 – 40.4) 9.0±8.4 (0 – 24.4)
Iris
diffuse atrophy 24/92.3 % 23.9±11.2 (9.0 – 37.5) 11.8±11.4 (0 – 36.5)
heterochromia 14/53.8 % 25.9±11.2 (9.8 – 37.5) 14.0±11.4 (0.8 – 36.5)
Vitreous cells 24/92.3 % 21.9±8.9 (8.8 – 39.6) 9.9±9.7 (0 – 33.1)
Vitreous haze≥1+ 16/61.5 % 21.9±8.0 (8.8 – 39.6) 9.8±9.4 (0.4 – 33.1)
Posterior synechiae 0/0 % / /
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distribution of KPs (0.8±0.6 and 1.2±1.2 years after uveitis
diagnosis, respectively).
The maximal AC cell grade during follow-up was 1+ in all
patients. Koeppe nodules, iris atrophy, and heterochromia were
observed after a mean of 9.0 (range 0 – 24.4; n=10 eyes), 11.8
(range 0 – 36.5; n=24 eyes), and 14.0 years (range 0.8 – 36.5;
n=14 eyes) of uveitis duration, respectively (Table 4). Cells
were found in the anterior vitreous cavity in 24 eyes (92.3 %)
after a mean of 9.9 years (range 0 – 33.1). Vitreous haze≥1+
[24] was observed in 16 out of 26 eyes (61.5 %) after a mean of
9.8 years following uveitis onset (range 0.4 – 33.1), Table 4.
In none of the FUS eyes were posterior synechiae observed
at any time point. Secondary complications, such as cataract
(19 eyes, 73.1 %), ocular hypertension (three eyes, 11.5 %), or
glaucoma (two eyes, 7.7 %), were diagnosed after a mean of
11.6 years (range 0 – 33.1), 19.48 years (range 17.0 – 23.4),
and 20.3 years (range 17.0 – 23.6), respectively (Table 5).
Macular edema was not found at any time point in these pa-
tients. Cataract surgery (14 eyes, 53.8 %), vitrectomy (7 eyes,
26.9 %), and glaucoma surgery (2 eyes, 7.7 %) were per-
formed after a mean uveitis duration of 11.7, 13.7, and
29.6 years, respectively. KPs did not differ between patients
with or without surgery (data not shown).
Figure 1 shows a selection of five patients who presented
with non-specific clinical signs in the beginning and in whom
typical FUS signs became manifest only at a later stage. In all
of them, KPs initially were located inferiorly, while diffuse
distribution of KPs – typical for FUS – appeared only during
the later course of disease. Initially, fine KPs were document-
ed, whereas stellate or mutton-fat KPs were seen either simul-
taneously (n=1 patient) or only during the further course of
disease (n=4 patients). The pattern did not differ between
patients who received (n=14) or did not receive (n=9) topical
corticosteroids. In all of these patients, vitreous cells and/or
haze were observed only at a later stage.
Discussion
Our data show that FUS may become manifest as soon as in
early childhood. As the initial clinical signs – especially in the
first months of uveitis onset – may not be pathognomonic for
FUS, a correct diagnosis may be difficult and is often delayed.
Especially in children, a slight decrease in visual acuity or
vitreous floaters may presumably go unnoticed for a longer
period of time. The differential diagnosis includes all other
anterior uveitis entities with insidious onset of flare, especially
juvenile idiopathic arthritis-associated uveitis (JIAU). Impor-
tant factors for diagnosing JIAU are antinuclear antibodies
(ANA), early onset≤4 years, and early/initial onset of compli-
cations [27]. On the other hand, clinical signs such as vitreous
cells are common in FUS, but rare in JIAU with a mild degree
of inflammation.
This study was performed at a tertiary uveitis center with
appropriate documentation and internationally acknowledged
uveitis nomenclature [24]. Nevertheless, we detected a
Table 5 Initial documentation of
secondary complications. Patients
(23 patients; 26 eyes) with Fuchs
uveitis syndrome becoming
manifest before the age of 16
years
N (eyes)/% Age (years) at initial
documentation
mean±SD (range)
Years after uveitis
diagnosis
mean±SD (range)
Cataract 19/73.1 % 23.8±9.5 (5.3 – 39.6) 11.6±10.0 (0 – 33.1)
Ocular hypertension 3/11.5 % 34.5±0.7 (34.0 – 35.5) 19.5±2.8 (17.0 – 23.4)
Glaucoma 2/7.7 % 34.8±0.9 (34.0 – 35.7) 20.3±3.3 (17.0 – 23.6)
Macular edema 0/0 % / /
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Fig. 1 Representative case series
of 5 patients with non-specific
uveitis signs in the beginning who
only developed typical signs of
Fuchs uveitis syndrome during
the further course of disease
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subgroup of patients with non-specific uveitis signs in the
beginning and in whom typical signs for FUS only became
manifest during the further course of disease. Interestingly, we
observed a change in the type of KPs: an inferior distribution
of fine and/or stellate KPs was found in early stage, whereas
no characteristic or pathognomonic clinical signs for FUS
were present. At a later stage, KP type changed to a diffuse
distribution of KPs, with mainly a fine and mutton-fat appear-
ance, which is typical for FUS.
For differential diagnosis, it has to be considered that stellate
KPsmay not only be seen in FUS, but have also been described
in uveitis due to sarcoidosis [28], toxoplasmosis [29], and viral
uveitis, for example, due to HSV, VZV, CMV, or rubella [30].
Our data suggest that stellate KPs are not always present at a
very early stage and may develop during the further course of
disease. Typical signs such as iris atrophy or heterochromia
were observed at a late stage. When these signs are seen as
early as at the first diagnosis of uveitis, they may indicate a
long-standing, subclinical course of disease. On the other hand,
subtle iris changes may go unrecognized.
Complications such as cataract, ocular hypertension, and
glaucoma have been found mainly in the third decade of life
(range from 5 – 40 years), with cataract as the predominant
complication. This highlights the necessity for an early diag-
nosis of FUS in order to avoid long-term treatment with cor-
ticosteroids, which may not be helpful in FUS.
In previous publications, bilateral manifestation was found
in 5-10 % of patients with FUS. This is in line with the results
of our present study. The characteristic findings of FUS may
be subtle, and FUS may be difficult to distinguish from other
uveitis entities, e.g., JIA-associated disease. Here, ANA pos-
itivity and the early development of synechiae and glaucoma
may help in differential diagnosis [27].
In conclusion, FUS may begin in early childhood, but di-
agnosis is often delayed for years, as the characteristic find-
ings may not be present at disease onset. This may occasion-
ally have the consequence of overtreatment with anti-
inflammatory drugs.
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